Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Melatonin in Peripartum Cardiomyopathy
NCT07334197Not yet recruiting
- Sponsor
- Tanta University
- Start
- Dec 2026
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of melatonin and selenium in Peripartum cardiomyopathy (PPCM) (4 arms), sponsored by Tanta University. Primary endpoints: Change in Left Ventricular Ejection Fraction at 3 months, Change in Left Ventricular End-Diastolic Dimension at 3 months and 1 more. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
melatoninselenium
03
Conditions
Peripartum cardiomyopathy (PPCM)
Beyond the preview
Go deeper on NCT07334197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07334197.